M032 + PEMBROLIZUMAB
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| M032 + PEMBROLIZUMAB for glioblastoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| M032 + PEMBROLIZUMAB for gliosarcoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |